Millions of Americans have successfully lost weight with semaglutides, the game-changing class of drugs that includes Ozempic, Mounjaro, and Wegovy. Still, many others are holding out for GLP-1 ...

A wellness boom looks to be reshaping China, with gyms and diet apps, alongside the new injectable weight-loss drugs, claiming wallet share A participant in a 2019 health festival in Hangzhou, China, ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.